Search
CA-170
go.drugbank.com/drugs/DB15772InvestigationalCA-170 is a selective, small molecule inhibitor of PD-L1.
Hu-rhEGF-rP64k/Mont
go.drugbank.com/drugs/DB15781InvestigationalHu-rhEGF-rP64k/Mont is a therapeutic vaccine composed by an antigen (recombinant human EGF (rhEGF) chemically conjugated to recombinant P64K (rP64K)) and an adjuvant (Montanide ISA51VG) being investigated
Products: CIMAVAX®EGFZinc phenolsulfonate
go.drugbank.com/drugs/DB15793ApprovedWithdrawnSynonyms: Zinc p-phenolsulfonate, Zinc p-phenolsulphonateMixtures: Racord Two 7, Siltrax Plus 7VPM1002
go.drugbank.com/drugs/DB15801InvestigationalVPM1002 is a recombinant BCG vaccine candidate expressing listeriolysin and deficient in urease that is generated in the genetic background of BCG Prague as it has a better safety profile than some other … This vaccine’s urease C gene is replaced with the listeriolysin O encoding gene from Listeria monocytogenes.
AV-COVID-19
go.drugbank.com/drugs/DB15802InvestigationalAV-COVID-19 is a vaccine composed of autologous dendritic cells loaded with SARS-CoV-2 antigens and with or without Granulocyte-macrophage colony-stimulating factor (GM-CSF). … As of July 2020, the company is pursuing an adaptive Phase IB-II Randomized Clinical Trial (NCT04386252) to test the vaccine.
CoronaVac
go.drugbank.com/drugs/DB15806InvestigationalCoronaVac, previously known as PiCoVacc, is a SARS-CoV-2 purified, inactivated, and adsorbed vaccine candidate developed by SinoVac Biotech Corporation[A219758]. … The antibodies were found to neutralize 10 representative SARS-CoV-2 strains. As of August 2020, the vaccine is being tested in numerous human clinical trials assessing its safety and immunogenicity.
BBIBP-CorV
go.drugbank.com/drugs/DB15807InvestigationalBBIBP-CorV vaccine contains a SARS-CoV-2 strain inactivated inside Vero Cells. … As of August 2020, this vaccine is being tested for prophylaxis against COVID-19 in human clinical trials.
Synonyms: Purified inactivated SARS-CoV-2 VaccineCIGB-258 peptide
go.drugbank.com/drugs/DB15809ExperimentalCIGB-258 is a peptide that is immunoregulatory and derived from heat shock protein 60 of the cellular variant. … As of 2020, The Center for Genetic Engineering and Biotechnology (CIGB) in Havana, Cuba, is testing the treatment efficacy of this peptide in patients with COVID-19 who are under intensive therapy regimens
Covid-19 Coronavirus Artificial Antigen Presenting Cell Vaccine
go.drugbank.com/drugs/DB15813InvestigationalAs of August 2020, this vaccine is being tested for prophylaxis against COVID-19 in human clinical trials. … Through analysis of potential immunogenic targets of the SARS-Cov2 genome, a synthetic ‘minigene’ was developed using domains of viral structural proteins and a polyprotein protease.
Fluocortolone caproate
go.drugbank.com/drugs/DB15821InvestigationalMixtures: ULTRALAN KREM, 10 G, ULTRALAN KREM, 20 G